AIM

#4754
AIM ImmunoTech Inc. Common Stock
0.3 9 USD
-7.14%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
0.39
0.39
년간 변동
0.21
20.35
일일 변동
-7.14%
월간 변동
-23.54%
6달 변화
-75.65%
년간 변동율
-95.41%
이전 종가
0.4 2
Open
0.3 9
저가
0.3 9
High
0.3 9
양
233
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 5.68 M
  • Employee 21
  • Founded N/A
  • CEO N/A
  • Website www.aimimmuno.com
  • Headquarter Delaware, United States
  • FIGI BBG000JL6Z80
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-0.13
주가매출액비율
20.76

AIM ImmunoTech Inc. Common Stock

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

뉴스